Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Zota Health Care LImited

₹ 1,3400.16%
16 Jan 10:09 a.m. – close price
🔗zotahealthcare.com•BSE: •NSE: ZOTA
Market Cap₹ 4,443 Cr.
Current Price₹ 1,340
High / Low₹ 1,740
Stock P/E217
Book Value₹ 149
Dividend Yield0.07 %
ROCE5.68 %
ROE3.93 %
Face Value₹ 10.0
Sales₹ 323 Cr.
OPM7.17 %
Mar Cap₹ 4,443 Cr.

ABOUT

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.[1]

KEY POINTS

Business segmentsDomestic sales (49% of FY21 revenue)[1]The is the oldest division and involves direct distribution of generic drugs, OTC products, and other pharmaceutical products through Company’s distribution network across India. Co. has 1050+ distributors across India and 3000+ products in its portfolio.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsRevenue GuidanceAsset Base ExpansionCapacity Expansion And ProductsPreferential IssuanceJv Partnerships Acquisitions

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Sun Pharma.Inds.1680.7034.96403256.280.953124.952.5614478.318.9320.2154964.0130.1211543.963117.955.1912.970.07
2.Divi's Lab.6344.9067.80168437.130.47689.0035.102715.0016.1220.4410029.0032.372485.00689.0010.9313.530.01
3.Torrent Pharma.4013.5062.68135835.080.81591.0032.493302.0014.3027.0512248.0032.602166.53600.1716.1013.260.33
4.Cipla1398.5020.77112966.810.941353.373.737589.447.6422.7228349.5725.405441.141351.173.4114.720.01
5.Lupin2214.5023.43101158.080.551484.8373.347047.5124.2321.3024750.6927.254324.631477.925.1412.410.32
6.Dr Reddy's Labs1193.2517.2699592.280.671336.807.288828.309.8322.6934310.0024.645772.201347.102.7712.950.16
7.Mankind Pharma2218.5552.4091582.860.04520.18-22.003697.1620.7715.9813545.6724.121748.55511.516.018.890.55
8.Zota Health Care1339.50216.854443.300.079.91321.7099.4268.485.68323.497.1720.499.919.013.120.00
–Median: 149 Co.397.1529.741769.320.1213.4912.32161.7610.5814.89591.7315.9345.2613.963.098.560.21

Quarterly Results

Standalone figures in ₹ crores

Dec 2022Dec 2023Dec 2024Jun 2023Jun 2024Jun 2025Mar 2023Mar 2024Mar 2025Sep 2022Sep 2023Sep 2024Sep 2025
Sales
34.0542.8368.1335.2552.2078.0136.2647.3577.9338.5741.1559.0199.42
Expenses
33.9140.7166.8234.6449.2570.8635.6846.9773.9933.3438.0655.7788.62
Operating Profit
0.142.121.310.612.957.150.580.383.945.233.093.2410.80
Other Income
0.800.381.690.360.472.230.770.691.500.980.630.973.27
Profit before tax
0.311.672.140.372.328.540.680.154.425.612.702.9613.07
Tax %
19.35%30.54%2.80%43.24%31.90%30.91%1.47%-46.67%41.18%24.78%33.70%20.61%24.18%
Net Profit
0.251.162.080.211.585.900.650.222.604.221.792.359.91
EPS in Rs
0.100.450.750.080.601.980.260.090.911.680.690.863.23

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
49566470778595106131138166256323
Expenses
43475560667790105116130160245300
Operating Profit
7810101185115861123
Other Income
0000222223259
Interest
1111000000010
Depreciation
1211112332333
Profit before tax
56881184-014951228
Net Profit
3456763-01173920
EPS in Rs
1.862.122.542.762.962.261.12-0.074.212.621.313.016.87
Dividend Payout %
38%34%28%52%72%32%89%-1,535%36%38%76%33%–

Compounded Profit Growth

10 Years:7%
5 Years:26%
3 Years:-7%
TTM:286%

Compounded Sales Growth

10 Years:17%
5 Years:22%
3 Years:25%
TTM:61%

Return on Equity

10 Years:7%
5 Years:5%
3 Years:4%
Last Year:4%

Stock Price CAGR

10 Years:%
5 Years:52%
3 Years:56%
1 Year:31%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
12141414181825252525262931
Reserves
4471352514442666996289425
Borrowings
5524-0-0-0-0-0-01502
Other Liabilities
13152023222120193430376259
Total Liabilities
3338445492908886125125173380517
Fixed Assets
98771010151413111212219
Gross Block
9.078.2314.4214.9818.7620.3628.0929.8431.1432.4535.9539.43–
Accumulated Depreciation
0.000.007.198.269.1910.5912.6815.8518.5821.0024.0127.18–
CWIP
-0-01202-00-03567
Investments
000-02616141035107116-0
Other Assets
243036455663596278101150246291
Total Assets
3338445492908886125125173380517

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
3453-4-36-114-10-30-22
Cash from Investing Activity
-1-1-1-2-269-44-2713-9-148
Cash from Financing Activity
-2-4-3-233-6-3-214-438171
Net Cash Flow
001-12-1-111-1-11

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
797790881099511299107115162147
Inventory Days
134175141193174207139139116148139138
Days Payable
104116126148118103827776102107107
Cash Conversion Cycle
108135105133165199169161147161194178
Working Capital Days
666785106151175152143112153172177
ROCE %
27%32%36%33%23%11%6%-2%18%9%5%6%

Shareholding Pattern

Numbers in percentages

Dec 2023Dec 2024Dec 2025Jun 2023Jun 2024Jun 2025Mar 2023Mar 2024Mar 2025Sep 2023Sep 2024Sep 2025
Promoters
66.15%62.02%51.56%68.12%64.44%57.42%68.12%66.15%59.72%66.16%62.40%55.81%
FIIs
0.00%0.24%8.00%0.04%0.01%3.82%0.00%0.00%0.87%0.02%0.01%3.49%
DIIs
0.00%1.03%6.09%0.00%0.00%4.25%0.00%0.00%3.08%0.00%0.99%4.95%
Public
33.85%36.71%34.35%31.84%35.55%34.52%31.88%33.85%36.33%33.83%36.60%35.75%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Zota Health Care Limited: Board Approves Equity Share Allotment Upon Warrant Conversion, Raising ₹4.1 Crore

2nd January 2026, 9:14 pm

Zota Health Care to Incorporate Wholly Owned Subsidiary 'KMHP Ventures Limited' for Pharma Marketing

2nd January 2026, 9:27 pm

Zota Health Care: Davaindia Store Network Expands Robustly in Q3FY26 Amidst Ongoing Growth Initiatives

1st January 2026, 10:30 pm

Zota Health Care Limited Announces Trading Window Closure Ahead of Q3 FY26 Results

26th December 2025, 6:11 pm

Zota Health Care Raises Rs 350 Crores via QIP to Fund Davaindia Expansion

25th December 2025, 12:34 am

Published by Other Websites

External media mentions & references

Zota Health: Investor Bets on Growth Amidst Widening Losses

6th February 2026, 5:57 am

Dhoni & Shetty Back Zota Health! ₹350 Cr Fundraise Ignites Massive Pharmacy Network Expansion!

29th December 2025, 12:24 pm

Zota Health Care Bags ₹350 Crore Funding Boost: Davaindia's Next Big Move Revealed?

22nd December 2025, 5:05 am

Zota Health Care Roars Back: ₹350 Crore QIP Boosts Shares – What Investors MUST Know NOW!

18th December 2025, 8:06 am

Zota Health Care's ₹400 Crore QIP: Discounted Price Sparks Investor Frenzy!

16th December 2025, 9:31 am

News Articles

Editorial & research coverage

Zota Health: Investor Bets on Growth Amidst Widening Losses
Zota Health: Investor Bets on Growth Amidst Widening Losses

6th February 2026, 5:57 am

Dhoni & Shetty Back Zota Health! ₹350 Cr Fundraise Ignites Massive Pharmacy Network Expansion!
Dhoni & Shetty Back Zota Health! ₹350 Cr Fundraise Ignites Massive Pharmacy Network Expansion!

29th December 2025, 12:24 pm

Zota Health Care Bags ₹350 Crore Funding Boost: Davaindia's Next Big Move Revealed?
Zota Health Care Bags ₹350 Crore Funding Boost: Davaindia's Next Big Move Revealed?

22nd December 2025, 5:05 am

Zota Health Care's ₹400 Crore QIP: Discounted Price Sparks Investor Frenzy!
Zota Health Care's ₹400 Crore QIP: Discounted Price Sparks Investor Frenzy!

16th December 2025, 9:31 am

Documents

Announcements

Clarification - Financial Results

13 January 2026 - Exchange has sought clarification from Zota Health Care LImited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. …

Certificate under SEBI (Depositories and Participants) Regulations, 2018

13 January 2026 - Certificate under Reg 74(5) confirming dematerialisation for quarter ended 31 Dec 2025.

Acquisition

2 January 2026 - Zota to incorporate wholly owned KMHP Ventures Ltd with paid-up equity Rs 10,00,000; Board approved Jan 02, 2026.

Allotment of Securities

2 January 2026 - Allotment of 1,07,556 shares at Rs.509 each on Jan 02, 2026; Rs.41,059,503 received; paid-up capital increased.

General Updates

1 January 2026 - Opened 276 Davaindia stores in Q3FY26; total stores 2,331 as of 31-12-2025.

Annual Reports

Financial Year 2025

(from nse)

Financial Year 2024

(from nse)

Financial Year 2023

(from nse)

Financial Year 2022

(from nse)

Financial Year 2021

(from nse)

Financial Year 2020

(from nse)

Financial Year 2019

(from nse)

Credit Ratings

No credit ratings.

Concalls

Nov 2025

TranscriptPPTRecording

Oct 2025

PPT

Aug 2025

TranscriptPPT

Jul 2025

PPT

Jun 2025

TranscriptPPT

Apr 2025

PPT

Feb 2025

PPT

Nov 2024

PPT

Aug 2024

PPT

May 2024

PPT

Feb 2024

PPT

Nov 2023

PPT

Jun 2023

PPT

Feb 2023

PPT

Nov 2022

PPT

Sep 2022

PPT

Jun 2022

PPT

Feb 2022

PPT

Dec 2021

PPT

Aug 2021

PPT

Jun 2021

PPT

Feb 2021

PPT

Dec 2020

PPT

Sep 2020

PPT

Jun 2020

PPT

Feb 2020

PPT

Stock Analysis

Description

  1. Zota Health Care Limited operates in the pharmaceutical and healthcare sector, with a focus on its retail pharmacy network, DavaIndia, and manufacturing of pharmaceutical formulations.

Key Growth Triggers

  1. Q2FY26 results showed significant YoY revenue growth (92%) and positive EBITDA.
  2. Plans include accelerated Davaindia store expansion (target 5,000 by FY29) supported by QIP fundraising, brand ambassador appointment (M.S. Dhoni), and increased stake in a subsidiary.

Order Book

  1. Currently no data available for Order Book.

Key Red Flags

  1. Currently no data available for Key Red Flags.

Key Dates To Watch

  1. Board meeting on January 02, 2026 (approved warrant conversion allotment).
  2. Q2FY26 results announced (October 17, 2025) and Earnings call (October 28, 2025).

Corporate Announcements

2nd Jan 26
Impact Rating: 6
Zota Health Care Limited reported Board approval for converting 1,07,556 warrants into equity shares, increasing paid-up capital and receiving ₹4.1 crore in exercise funds.
2nd Jan 26
Impact Rating: 3
Zota Health Care Limited will invest ₹10,00,000 to hold a 100% stake in its newly approved wholly-owned subsidiary, KMHP Ventures Limited, which will operate in the pharmaceutical marketing and trading sector.
1st Jan 26
Impact Rating: 6
Zota Health Care's Davaindia stores expanded by 276 in Q3FY26, following strong Q2FY26 financial performance and strategic growth initiatives.
26th Dec 25
Impact Rating: 4
Zota Health Care Limited has informed the exchange that its trading window for dealing in securities will be closed from January 1, 2026, in anticipation of the Q3 and nine-month FY26 financial results.
24th Dec 25
Impact Rating: 8
Zota Health Care has raised ₹350 crores from QIP, including participation from marquee investors. Proceeds will fuel Davaindia's COCO store expansion and working capital needs, supporting a target of 5,000 stores by 2029.